Skip to main content
. 2014 Feb 10;99(5):E891–E901. doi: 10.1210/jc.2013-2657

Table 2.

Cortisol Levels Before and After Treatment of Each Patient, for Each Treatment Arm (Octreotide and Placebo)

Treatment Arm Patient Pretreatment Period
Posttreatment Period
Posttreatment Means Expressed as Percentage of Pretreatment Means Change From Pretreatment Mean to Posttreatment Mean, %
Cortisol Mean AUC Cortisol Mean AUC
Octreotide 1 15.0 176.5 2.1 22.7 14.1 −85.9
2 8.8 105.1 8.4 87.2 95.0 −5.0
3 33.5 401.4 28.3 239.4 84.6 −15.4
4 4.2 50.2 4.3 45.0 102.3 2.3
5 4.4 50.6 5.0 50.5 114.0 14.0
6 26.2 315.9 25.4 280.7 96.9 −3.1
7 5.3 64.8 5.0 55.6 94.3 −5.7
8 9.2 78.6 8.8 95.7 94.7 −5.3
9 30.4 365.5 31.1 201.6 102.0 2.0
10 8.2 90.5 8.2 90.7 99.8 −0.2
Total 14.5 (11.3) 169.9 (138.1) 12.6 (11.0) 116.9 (90.2) 89.8 (27.6) −10.2 (27.6)
Placebo 1 49.1 593.7 19.3 206.1 39.4 −60.6
2 12.0 145.3 11.1 116.2 92.0 −8.0
3 29.1 350.9 25.0 263.0 85.9 −14.1
4 4.3 52.1 6.1 64.6 140.6 40.6
5 3.0 36.7 5.5 57.4 181.1 81.1
6 25.1 300.7 22.1 241.4 88.1 −11.9
7 4.8 57.6 4.9 55.1 102.9 2.9
8 6.7 79.2 10.5 115.9 157.1 57.1
9 28.2 337.4 28.4 313.5 100.6 0.6
10 8.7 104.2 8.2 89.0 93.7 −6.3
Total 17.1 (15.2) 205.8 (183.2) 14.1 (8.8) 152.2 (95.4) 108.1 (40.8) 8.1 (40.8)

P = .2541 comparing percentage of change from before treatment to after treatment. P = .4260 comparing octreotide with placebo cortisol AUC, pretreatment period. P = .1824 comparing octreotide with placebo cortisol AUC, posttreatment period. P < .0001 comparing before treatment with after treatment using repeated measures, octreotide (same adjusted for sex). P < .0001 comparing before treatment with after treatment using repeated measures, placebo (same adjusted for sex).